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Robotic surgery outcomes after the learning curve:  Does robotic surgery improve the 
quality health outcome “readmission <30 days” in patients having hysterectomy for benign disease? 
Elizabeth A. Berger DO3, Jocelyn Shubella1,  Martin A. Martino MD1,2
The objective of this study was to evaluate quality outcomes 
in high-volume surgeons after benign gynecologic surgery.  
•  The primary outcome measure was “Readmission <30 days”. 
•  Secondary outcome measures included cost of 
readmissions, diagnosis for readmissions, EBL and LOS.    










Age 56 49 47 50
BMI 29.1 31.6 29.8 31.8
All patients who underwent a hysterectomy for benign disease 
from 6/2006-6/2011 were extracted from our database and 
de-identified.  Patients were grouped by 4 surgical routes: 
robotic, vaginal, laparoscopic, open. 
•  Inclusion criteria for high volume surgeons were completion 
of 20 cases in any given year. 
   —  The first 20 cases within each cohort were considered 
part of the learning curve and removed from analysis to 
measure “after the learning curve.” 
Demographic data reviewed included age and BMI.  Groups 
were compared using chi-square and logistic regression. This 
study was IRB-approved at LVHN.
Methods:
A total of 1119 patients (179 robotic, 235 vaginal, 255 
laparoscopic, 450 open) met the inclusion criteria. The 
readmission rate for patients having robotic hysterectomy 
was 1.1% (2/179) compared with 5.1% (12/235) of patients 
who had vaginal hysterectomy (p=0.03, odds ratio [OR] = 4.8, 
95% confidence interval [CI] 0.0078 – 0.0720). Readmission 
rates for cases performed via laparoscopy and open were 
similar to vaginal hysterectomy, respectively, 4.7% (12/255), 
6.9% (31/450) and 5.1% (p=0.84, p=0.36). The sum of cost for 
vaginal, laparoscopic, open and robotic-assisted routes of 
hysterectomies were $76,300, $97,840, $354,855, and $16,525, 
respectively. 
Results:
After the learning curve, patients who had a vaginal, 
laparoscopic or open hysterectomy for benign disease had a 
3-fold higher chance to be readmitted within 30 postoperative 
days compared to patients who had a robotic hysterectomy.    
Conclusion:
 Table 2. Estimated Blood Loss (EBL) and Length of Stay (LOS) 











EBL (mL) 318 103 p<.01 196 p<0.1 395 p<.04
LOS (min) 2495 1989 p<.01 2123 p<.003 5935 p<0.1










Fever/Infection 8 0 4 5
Wound Complication 0 0 0 11
Medical Co-morbidity 4 0 2 7
Vaginal Bleeding 0 0 3 0
Uncontrolled Pain 0 2 1 1
Bowel Issues (Ileus or 








Total Cost $76,300 $16,525 $97,840 $354,855
